Sartorius AG (Sartorius) develops laboratory and process technology equipment. Its product portfolio offers products in pharmaceutical, biotechnology, chemical, food and beverage industries, and numerous research and educational institutes in the public sector in Germany and overseas.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Research and development (R&D) focus on investing in the development of new and advanced technologies, and a strong patent and product portfolio. It conducts cross-divisional research and development with a view to long-term technological topics and collaborate with external companies. It works to identifying and developing key technologies and application fields of the future. The company entered into partnership with BICO Group to provide valuable input for innovative applications such as field of 3D cell printing. The company allocated EUR95.5billion of research and innovation funding is to be provided in the period from 2021 to 2027, an increase of 19% compared with the previous program. The company partnered with research institutes, and startups, Corporate Research to provide innovative technologies in live cell analysis, materials with new functionalities and improved properties, and data analysis. As of December 2022, the company owns 6,421 patents, issued 353 patents and trademarks, and filed 261 applications for intellectual and industrial property rights. In FY2022, it spent EUR177.8 million on R&D, which stood at 4.3% of its revenue and grew 27.1% YoY.